Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase 4, Open Label, Multicentre, 2 Year Safety Study of Lisdexamfetamine Dimesylate in Children/Adolescents With ADHD (SPD489-404)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2011 by Maastricht University Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Shire
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01413165
First received: August 9, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)